Investor Relations
home » Investor Relations » Investor Relations Home

Investor Relations Home

Corporate Profile

Inovio Pharmaceuticals (NYSE Amex: INO) is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines. A comprehensive description of Inovio, its product pipeline, and its leading More >>

 

Recent News
Investor Alerts
Jan 11, 2012
Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
Jan 5, 2012
Inovio Pharmaceuticals to Present at Biotech Showcase Investor Conference
Jan 4, 2012
Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
Stock Quote
Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Inovio Pharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.

 


Print Email RSS